by Guillaume Girard

1. Sars precedents and the hijacking of virological research
Coronaviruses have been studied for a long time

Coronaviruses (“crown” viruses) are a large family known since the 301s2, common to humans and animals2002, such as those of human bronchitis or mouse hepatitis for example. Dedicated studies have multiplied since the first Sars epidemic in XNUMX.
The youngest are not affected by the respiratory syndrome, only the very old die

The lethality of Sars-Cov-1 (2002) and Mers (2012) is limited to the elderly or immunocompromised, and this also applies to Sars-Cov-2, despite specific mutations giving it greater contagiousness. The rate of infection in the general population is low3 and the lethality is at the level of seasonal influenza.4

Spike protein is well known

The “spike”, in French spike protein, is a protein common to many viruses. It is an infectious and inflammatory protein, a virotoxin. That of coronaviruses is well documented5; it has been the subject of numerous publications, even patents6,7, sometimes filed explicitly for vaccine purposes8, and possibly relating to an entire coronavirus9. Three American researchers, including Ralph Baric, still regularly under contract with the National Institutes of Health (NIH), filed a patent2002 in early 10 on methods for producing recombinant coronaviruses, at the dawn of the first Sars epidemic. In 2004, it was the turn of the Institut Pasteur and the CNRS to file a patent on a strain of Sars coronavirus.11

“Gain of function” is a proven practice and meant to be framed

The practices of biotechnology consisting in inserting one or portions of the genome into an existing genome are practiced, secretly or officially, in all the countries having laboratories and qualified scientists, in particular in the USA, but also in Canada, in China. Given the health risks incurred, a moratorium imposed the suspension of these practices on American soil in 201412; partially lifted in 201713, it is proposed to renew it in 202114. Between 2015 and 2017, Ralph Baric and his colleague Boyd Yount filed several successive versions of a patent relating to chimeric “spike” proteins.15

Military research is outsourced

Many establishments carry out research around viruses, including coronaviruses, in particular at the initiative of the United States or China. DARPA16 is the US military research agency that has funded biological agent research programs for many years. One of its main subcontractors is Moderna, of which Stéphane Bancel, the current CEO, is co-holder of a 2017 patent on an mRNA for oncology17. In addition, the officially non-governmental EcoHealth Alliance is a multi-million dollar organization from the US government. Directed by Peter Daszack, it has, among other things, funded the Wuhan laboratory for its research on gain of function, in partnership with the University of North Carolina (USA). The funding circuits for this outsourced work are detailed in Michel Cucchi's work, “Influences and Pandemics”18. Some of this funding comes from the “Pentagon”, the Department of Defence19, which also supports various private research structures via consortia20,21 within which there are many pharmaceutical companies.22
The WHO is infiltrated by “philanthropic capitalism”

access the document